<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04710095</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#15-000237</org_study_id>
    <secondary_id>R21AA023669</secondary_id>
    <nct_id>NCT04710095</nct_id>
  </id_info>
  <brief_title>Perceived Alcohol Rewards and Risks Study</brief_title>
  <acronym>PARS</acronym>
  <official_title>Perceived Alcohol Reward Value and Risk: Neural Correlates and Treatment Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The identification of mechanisms that underlie how people reduce or eliminate alcohol use is&#xD;
      a critical public health issue. Understanding these mechanisms can inform how to effectively&#xD;
      intervene with problem drinkers. Thus far it has been a challenge for the alcohol research&#xD;
      field to find consistent empirical evidence in support of candidate mechanisms of behavior&#xD;
      change. Scientific advancement in this area may be aided by longitudinal transdisciplinary&#xD;
      research on the interplay between behavioral intervention, cognition, and brain activity to&#xD;
      understand underlying processes of behavior change among heavy drinkers. This study employed&#xD;
      a randomized 2-arm repeated measures design with a sample of non-treatment seeking adult&#xD;
      heavy drinkers to examine changes in perceived reward value and risks of alcohol use as a&#xD;
      mechanism of alcohol behavior change after a brief behavioral intervention. Participants were&#xD;
      randomized to either a 1-session behavioral intervention or to an attention-matched control&#xD;
      condition and immediately after completed an fMRI scan. The focus of this project is to&#xD;
      examine if group differences in perceived alcohol reward value after the intervention&#xD;
      mediates an intervention effect on reducing alcohol use in the 1 month following the&#xD;
      intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 13, 2015</start_date>
  <completion_date type="Actual">April 5, 2017</completion_date>
  <primary_completion_date type="Actual">April 5, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Heavy Drinking Days</measure>
    <time_frame>4 weeks post intervention</time_frame>
    <description>Percent heavy drinking days defined as 5+ drinks for men and 4+ for women according to self-reported Timeline Follow Back (TLFB) data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neural Alcohol Cue Reactivity</measure>
    <time_frame>Single time point immediately post intervention</time_frame>
    <description>Neural alcohol cue reactivity as measured by whole brain activation to alcohol taste cue vs. water taste cue using functional magnetic resonance imaging (fMRI)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Heavy Drinking</condition>
  <arm_group>
    <arm_group_label>Brief Alcohol Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A brief intervention consisting of a 30-45 minute individual face-to-face session based on the principles of motivational interviewing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attention-Matched Control Condition</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Brief attention-matched control condition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief Alcohol Intervention</intervention_name>
    <description>Brief alcohol intervention uses a motivational interviewing approach and covers the following components: giving information about the possible health risks associated with alcohol use, placing the responsibility for change on the individual, discussing the reasons for drinking and downsides of drinking, and setting a goal and change plan if the participant is receptive.</description>
    <arm_group_label>Brief Alcohol Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control Condition</intervention_name>
    <description>The attention-matched control condition consisting of a 30-min video about astronomy.</description>
    <arm_group_label>Attention-Matched Control Condition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. engaged in regular heavy drinking, as indicated by consuming 5 or more drinks per&#xD;
             occasion for men or 4 or more drinks per occasion for women at least 4 times in the&#xD;
             month prior to enrollment&#xD;
&#xD;
          2. a score of â‰¥ 8 on the Alcohol Use Disorder Identification Test (AUDIT)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. under the age of 21&#xD;
&#xD;
          2. currently receiving treatment for alcohol problems, history of treatment in the 30&#xD;
             days before enrollment, or currently seeking treatment&#xD;
&#xD;
          3. a positive urine toxicology screen for any drug other than cannabis&#xD;
&#xD;
          4. a lifetime history of schizophrenia, bipolar disorder, or other psychotic disorder&#xD;
&#xD;
          5. serious alcohol withdrawal symptoms&#xD;
&#xD;
          6. history of epilepsy, seizures, or severe head trauma&#xD;
&#xD;
          7. non-removable ferromagnetic objects in body&#xD;
&#xD;
          8. claustrophobia&#xD;
&#xD;
          9. pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lara A Ray, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mitchell P Karno, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <results_reference>
    <citation>Grodin EN, Ray LA, MacKillop J, Lim AC, Karno MP. Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study. Alcohol Clin Exp Res. 2019 Feb;43(2):367-377. doi: 10.1111/acer.13941. Epub 2019 Jan 20.</citation>
    <PMID>30556913</PMID>
  </results_reference>
  <results_reference>
    <citation>Grodin EN, Lim AC, MacKillop J, Karno MP, Ray LA. An Examination of Motivation to Change and Neural Alcohol Cue Reactivity Following a Brief Intervention. Front Psychiatry. 2019 Jun 11;10:408. doi: 10.3389/fpsyt.2019.00408. eCollection 2019.</citation>
    <PMID>31244697</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 12, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>January 20, 2021</last_update_submitted>
  <last_update_submitted_qc>January 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Lara Ray, PhD</investigator_full_name>
    <investigator_title>Co-Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

